GB9308963D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9308963D0
GB9308963D0 GB939308963A GB9308963A GB9308963D0 GB 9308963 D0 GB9308963 D0 GB 9308963D0 GB 939308963 A GB939308963 A GB 939308963A GB 9308963 A GB9308963 A GB 9308963A GB 9308963 D0 GB9308963 D0 GB 9308963D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939308963A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB939308963A priority Critical patent/GB9308963D0/en
Publication of GB9308963D0 publication Critical patent/GB9308963D0/en
Priority to JP6523863A priority patent/JPH08512199A/en
Priority to CN94192620.6A priority patent/CN1126492A/en
Priority to PCT/EP1994/001297 priority patent/WO1994025600A1/en
Priority to EP94915539A priority patent/EP0695358A1/en
Priority to AU69648/94A priority patent/AU6964894A/en
Priority to CA002161645A priority patent/CA2161645A1/en
Priority to KR1019950704819A priority patent/KR960702000A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
GB939308963A 1993-04-30 1993-04-30 Novel compounds Pending GB9308963D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GB939308963A GB9308963D0 (en) 1993-04-30 1993-04-30 Novel compounds
JP6523863A JPH08512199A (en) 1993-04-30 1994-04-26 Use in mumps virus-derived recombinant antigens and vaccines
CN94192620.6A CN1126492A (en) 1993-04-30 1994-04-26 Recombinant antigens from mumps virus and their use in vaccines
PCT/EP1994/001297 WO1994025600A1 (en) 1993-04-30 1994-04-26 Recombinant antigens from mumps virus and their use in vaccines
EP94915539A EP0695358A1 (en) 1993-04-30 1994-04-26 Recombinant antigens from mumps virus and their use in vaccines
AU69648/94A AU6964894A (en) 1993-04-30 1994-04-26 Recombinant antigens from mumps virus and their use in vaccines
CA002161645A CA2161645A1 (en) 1993-04-30 1994-04-26 Recombinant antigens from mumps virus and their use in vaccines
KR1019950704819A KR960702000A (en) 1993-04-30 1994-04-26 RECOMBINANT ANTIGENS FROM MUMPS VIRUS AND THEIR USE IN VACCINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308963A GB9308963D0 (en) 1993-04-30 1993-04-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB9308963D0 true GB9308963D0 (en) 1993-06-16

Family

ID=10734747

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939308963A Pending GB9308963D0 (en) 1993-04-30 1993-04-30 Novel compounds

Country Status (8)

Country Link
EP (1) EP0695358A1 (en)
JP (1) JPH08512199A (en)
KR (1) KR960702000A (en)
CN (1) CN1126492A (en)
AU (1) AU6964894A (en)
CA (1) CA2161645A1 (en)
GB (1) GB9308963D0 (en)
WO (1) WO1994025600A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) * 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
WO1998052603A2 (en) * 1997-05-23 1998-11-26 Schweiz. Serum- & Impfinstitut Bern An influenza enveloped dna vaccine
WO1998040492A1 (en) 1997-03-11 1998-09-17 Cambridge Genetics Limited Compositions and methods for elimination of unwanted cells
AU5980899A (en) * 1998-09-25 2000-04-17 Smithkline Beecham Biologicals (Sa) Novel compounds
CN1843507B (en) * 2006-02-14 2010-04-21 中国医学科学院医学生物学研究所 Mumps virus ingredient vaccine for human, and its preparation method and uses
CN106290862B (en) * 2016-08-05 2017-10-31 北京市华信行生物科技有限公司 Mumps virus HN antigens and its purposes in detection material for anti parotitis antiviral antibody
AU2020402106A1 (en) * 2019-12-11 2022-07-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mumps and Measles virus immunogens and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011534A1 (en) * 1988-05-24 1989-11-30 Board Of Regents, The University Of Texas System Mumps virus hemagglutinin-neuraminidase

Also Published As

Publication number Publication date
AU6964894A (en) 1994-11-21
KR960702000A (en) 1996-03-28
CN1126492A (en) 1996-07-10
EP0695358A1 (en) 1996-02-07
CA2161645A1 (en) 1994-11-10
WO1994025600A1 (en) 1994-11-10
JPH08512199A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
GB9311661D0 (en) Novel compounds
GB9302275D0 (en) Novel compounds
AP9400653A0 (en) Novel compounds
GB9306460D0 (en) Novel compounds
GB9315148D0 (en) Novel compounds
GB9306183D0 (en) Novel compounds
GB9310485D0 (en) Novel compounds
GB9311644D0 (en) Novel compounds
GB9308963D0 (en) Novel compounds
GB9303825D0 (en) Novel compounds
GB9306182D0 (en) Novel compounds
GB9306235D0 (en) Novel compounds
GB9308178D0 (en) Novel compounds
GB9307694D0 (en) Novel compounds
GB9306236D0 (en) Novel compounds
GB9311567D0 (en) Novel compounds
GB9307477D0 (en) Novel compounds
GB9306459D0 (en) Novel compounds
GB9302770D0 (en) Novel compounds
GB9315963D0 (en) Novel compounds
GB9315930D0 (en) Novel compounds
GB9302273D0 (en) Novel compounds
GB9315147D0 (en) Novel compounds
GB9303607D0 (en) Novel compounds
GB9302769D0 (en) Novel compounds